Search results
With Measles on the Rise, Here's How to Check If You Were Vaccinated or Have Immunity
Scientific American· 3 days agoThe U.S. is in the midst of one of its largest measles outbreaks since the disease was declared...
Tractor Supply Company to Pay $75,000 to Settle EEOC Disability Discrimination and Retaliation...
JD Supra· 19 hours agoHeadquartered in Tennessee, Tractor Supply Company, the nation’s largest rural lifestyle retailer...
The world needs to understand the seriousness of HIV/AIDS
Daily Sundial· 3 days agoIn the early 1980s, a mysterious disease plagued several people, predominantly gay men. This disease...
Mom of TikTok's Bella Brave Responds to Vicious Online Bullying of Daughter: 'Ignite a Change'...
People via Yahoo News· 6 days agoKyla Thomson's 10-year-old lives with Hirschsprung’s disease and severe combined immunodeficiency,...
Mom of TikTok’s ‘Bella Brave’ speaks out after online bullies attack one of her videos
Motherly via Yahoo News· 16 hours agoThe account has more than 7 million followers, and Thompson is hoping to bring advocacy for...
The Cleaning Lady: Season Four; 2024-25 Renewal Announced for FOX Crime Drama Series
TV Series Finale· 2 days agoThony's troubles are far from over. FOX has renewed The Cleaning Lady for a fourth year which will...
Merit Financial Group LLC Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 days agoMerit Financial Group LLC lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned ...
ADMA Biologics (NASDAQ:ADMA) Given New $10.00 Price Target at Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoADMA Biologics (NASDAQ:ADMA – Free Report) had its target price upped by Cantor Fitzgerald from $8.00 to $10.00 in a research report report published on Friday morning, Benzinga reports. A number ...
ADMA Biologics (NASDAQ:ADMA) Price Target Raised to $10.00 at Raymond James
ETF DAILY NEWS· 3 days agoADMA Biologics (NASDAQ:ADMA – Free Report) had its price objective upped by Raymond James from $8.00 to $10.00 in a report issued on Friday morning, Benzinga reports. Mizuho lifted their price ...
Hologic, Inc. (NASDAQ:HOLX) Receives Average Recommendation of “Moderate Buy” from Brokerages
ETF DAILY NEWS· 5 days agoShares of Hologic, Inc. (NASDAQ:HOLX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the company, Marketbeat.com ...